JAK-IN-32

• UNSPSC Description:

  JAK-IN-32 (XC) is a bi-aryl meta-pyrimidine inhibitor of JAK kinase[1].

• Target Antigen:

  JAK

• Type:

  Reference compound

• Related Pathways:

  Epigenetics;JAK/STAT Signaling;Protein Tyrosine Kinase/RTK;Stem Cell/Wnt

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/jak-in-32.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC(C)(NS(C1=CC=CC(NC2=NC(NC3=CC(CN4CCOCC4)=CC=C3)=NC=C2C)=C1)(=O)=O)C

• Molecular Weight:

  510.65

• References & Citations:

  [1]Glenn Noronha, et al. Bi-aryl meta-pyrimidine inhibitors of kinases. Patent. US20110212077A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  936091-56-4